Clinical trial

Clinical Trial of Comparative Study of GB221 Pharmacokinetics

NCT04175171

Drugs and interventions used in this trial

2 registered

These interventions are listed by ClinicalTrials.gov. An RxNorm link indicates a mapped medicine record; the registry name alone is not proof of a specific branded formulation.

Search this trial's interventions

DRUG · Unmapped registry intervention Coprelotamab Injection Find medicine records · Find other trials using this name

DRUG · Mapped RxNorm record Trastuzumab Injection Normalized identity: trastuzumab InjectionView linked drug · Find medicine records · Find other trials using this name

Study at a glance

Registry-backed

Clinical Trial of Comparative Study of GB221 Pharmacokinetics

Design: INTERVENTIONAL · Status: COMPLETED · Phase: PHASE1

Read study objectives, eligibility and outcome measures at ClinicalTrials.gov

StatusCOMPLETED

Study typeINTERVENTIONAL

Start date2011-11-07

PhasePHASE1

Conditions

Metastatic Breast Cancerunresolved

Interventions

Coprelotamab InjectionDRUG

Trastuzumab InjectionDRUG · verified · RxNorm: trastuzumab Injection

Sponsors & collaborators

Genor Biopharma Co., Ltd.lead sponsor

Registry source

Open the source record to verify current eligibility, contacts, locations and registry updates.

Open NCT04175171 on ClinicalTrials.gov ↗

Registry-derived research relationships: ClinicalTrials.gov. Raw condition and intervention labels remain distinct from canonical MONDO/RxNorm entities unless separately normalized.